Last reviewed · How we verify

NCT02893423: TAPROPI

Ropivacaine Transversus Abdominis Plane Blocks for Cesarean Section Analgesia

Terminated NA Results posted Last updated 21 September 2022
What this trial tests

NA trial testing Ropivacaine in Postoperative Pain in 51 participants. Terminated before completion.

Timeline
1 January 2013
Primary endpoint
30 September 2016
30 September 2016

Quick facts

Lead sponsorMaimonides Medical Center
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment51
Start date1 January 2013
Primary completion30 September 2016
Estimated completion30 September 2016
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Maimonides Medical Center

Who can join

Eligibility, female only, with Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

POSTOPERATIVE PAIN Primary · 48 hours

Severity of postoperative pain will be assessed using(VAS) scale. Post-operative pain scale name: Visual Analog Scale (0-10) with 0 being no-pain and 10 being maximum pain.

GroupValue95% CI
Group 1 - 0.5% Ropivacaine2.35± 3.08
Group 2 - 0.25% Ropivacaine1.94± 2.77
Group 3 - No Tap Block0.56± .922

Sponsor's own description

With this research the investigators hope to determine the lowest dose of ropivacaine used in transversus abdominis plane (TAP) blocks that can effectively treat pain in women after cesarean section (c-section).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ropivacaine

Trials testing the same drug.

Other recruiting trials for Postoperative Pain

Currently open trials in the same condition.

Other Maimonides Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02893423.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing